Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Blood
|
March 1, 1988
Heme arginate: effects on hemostasis
L Volin, V Rasi, E Vahtera, et al.
Transfusion Medicine (Oxford, England)
|
March 30, 2010
Prothrombin activation fragment 1 + 2 as a marker of coagulation activation in cord blood collection for banking
S Juutistenaho, E Vahtera, K Aranko, et al.
British Journal of Haematology
|
October 1, 1991
Familial clustering of defective release of t-PA
J Petäjä, V Rasi, E Vahtera, et al.
Duodecim; Laaketieteellinen Aikakauskirja
|
January 1, 1988
[Short-acting fibrinolysis in the etiology of venous thrombosis]
J Petäjä, G Myllylä, V Rasi, et al.
Duodecim; Laaketieteellinen Aikakauskirja
|
January 1, 1995
[APC resistance and blood coagulation factor V mutation in Finnish thrombotic patients]
L Hakala, E Vahtera, T Krusius, et al.
European Journal of Radiology
|
February 1, 1988
Decrease of plasma prekallikrein and kallikrein inhibitors during intravenous phlebography
H J Aronen, I Torstila, E Vahtera, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
June 19, 2001
Weight change and blood coagulability and fibrinolysis in healthy obese women
P Rissanen, E Vahtera, T Krusius, et al.
Atherosclerosis
|
June 8, 2001
The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project
P Jousilahti, V Salomaa, V Rasi, et al.
Duodecim; Laaketieteellinen Aikakauskirja
|
January 1, 1984
[A new hereditary thrombotic disease--protein C deficiency]
G Myllylä, V Rasi, E Vahtera, et al.
Journal of Epidemiology and Community Health
|
August 23, 2003
Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status
P Jousilahti, V Salomaa, V Rasi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Blood
|
March 1, 1988
Heme arginate: effects on hemostasis
L Volin, V Rasi, E Vahtera, et al.
Transfusion Medicine (Oxford, England)
|
March 30, 2010
Prothrombin activation fragment 1 + 2 as a marker of coagulation activation in cord blood collection for banking
S Juutistenaho, E Vahtera, K Aranko, et al.
British Journal of Haematology
|
October 1, 1991
Familial clustering of defective release of t-PA
J Petäjä, V Rasi, E Vahtera, et al.
Duodecim; Laaketieteellinen Aikakauskirja
|
January 1, 1988
[Short-acting fibrinolysis in the etiology of venous thrombosis]
J Petäjä, G Myllylä, V Rasi, et al.
Duodecim; Laaketieteellinen Aikakauskirja
|
January 1, 1995
[APC resistance and blood coagulation factor V mutation in Finnish thrombotic patients]
L Hakala, E Vahtera, T Krusius, et al.
European Journal of Radiology
|
February 1, 1988
Decrease of plasma prekallikrein and kallikrein inhibitors during intravenous phlebography
H J Aronen, I Torstila, E Vahtera, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
June 19, 2001
Weight change and blood coagulability and fibrinolysis in healthy obese women
P Rissanen, E Vahtera, T Krusius, et al.
Atherosclerosis
|
June 8, 2001
The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project
P Jousilahti, V Salomaa, V Rasi, et al.
Duodecim; Laaketieteellinen Aikakauskirja
|
January 1, 1984
[A new hereditary thrombotic disease--protein C deficiency]
G Myllylä, V Rasi, E Vahtera, et al.
Journal of Epidemiology and Community Health
|
August 23, 2003
Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status
P Jousilahti, V Salomaa, V Rasi, et al.
Page
of 5